VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1650323
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Menstruation came 2 weeks early (2 weeks right after my cycle ended); heavier flow; This is a spontaneous report from a non-contactable consumer, the patient. A 31-year-old non-pregnant female received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date in 2021 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. On an unknown date, after receiving the first dose, the patient had menstruation came 2 weeks early (2 weeks right after cycle ended) and heavier flow. Patient stated that this had never happened before. The clinical outcome of the event menstruation irregular and heavier flow were unknown at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1650324
Sex: M
Age:
State: NJ

Vax Date: 04/10/2021
Onset Date: 04/12/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Very uncomfortable; Wrist and knuckle joints are having pain; This is a spontaneous report from a non-contactable consumer, the patient. A 62-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534/ER8729), via an unspecified route of administration in the right hand on 10Apr2021 (at the age of 62-year-old), as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not receive any other medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 12Apr2021, the patient experienced very uncomfortable and wrist and knuckle joints are having pain. It was reported that the patient could not even wash face with the right hand due to pain. The pain was bearable but very uncomfortable when it comes to doing things. The events resulted in doctor/other health care professional office/clinic visit. No therapeutic measures were taken for the events. The clinical outcome of very uncomfortable and wrist and knuckle joints are having pain was not recovered at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1650325
Sex: F
Age:
State: CO

Vax Date: 03/24/2021
Onset Date: 03/26/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Severe chills for a couple days; nausea; very tired; felt unwell; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in left arm on 24Mar2021 at 16:00, as single dose for COVID-19 immunisation. Medical history included diverticulitis, IBD and allergy to penicillin. The patient previously took codeine (MANUFACTURER UNKNOWN) and experienced drug allergy. Concomitant medication included levothyroxine sodium (SYNTHROID), antidepressant, allergy meds, ESTROVEN; all from an unknown start date and for unknown indication. Prior to vaccination, patient was not diagnosed with COVID-19; Since the vaccination, patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 26Mar2021, patient experienced severe chills for couple of days, nausea, very tired and felt unwell for 3-4 days. The patient did not receive any treatment for the reported events. The adverse event did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of the event severe chills, nausea, very tired and felt unwell were recovered on an unknown date in 2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: SYNTHROID

Current Illness:

ID: 1650326
Sex: M
Age:
State: PA

Vax Date: 03/30/2021
Onset Date: 03/31/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Ringing in ears/ hissing in ears; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EP6955) via an unspecified route of administration in the left arm on 30Mar2021 at 09:00 (at the age of 65-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported and the patient was allergic to horse serum. The patient received medication (UNSPECIFIED) within two weeks of vaccination. The patient previously took levaquin (MANUFACTURER UNKNOWN) for unknown indication on unknown date and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 05:00, the patient experienced ringing and hissing in ears, more in left ear. No therapeutic measures were taken as a result of adverse events. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events ringing and hissing in ears was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650327
Sex: F
Age:
State: TX

Vax Date: 04/10/2021
Onset Date: 04/12/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Large red circle; swollen around injection site; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: ER8734) via an unspecified route of administration in the left arm on 10Apr2021 at 13:30 (at the age of 46-year-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient had no allergies to medications, food, or other products. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Since the vaccination, the patient had not been tested for COVID-19. On 12Apr2021 the patient experienced large red circle and swollen around injection site. No therapeutic measures were taken as a result of the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events of large red circle and swollen around vaccination site was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650328
Sex: F
Age:
State:

Vax Date: 04/11/2021
Onset Date: 04/11/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Fatigued; headache; This is a spontaneous report from a non-contactable consumer, the patient. A 26-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 11Apr2021 at 14:00 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. The patients' medical history was reported as none. It was unknown if the patient was pregnant. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies to medications, food or other products. The patient did not receive any medication within two weeks of the COVID-19 vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 21Mar2021 at 11:30 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 11Apr2021, at 17:45 the patient experienced headache which came and went. On 12Apr2021, the day after vaccination the patient felt fatigued and the patient reported that the pain intensity had decreased. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as the result of adverse events. The clinical outcome of the events headache and fatigue were recovering at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1650329
Sex: F
Age:
State: IN

Vax Date: 04/13/2021
Onset Date: 04/13/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Loud non-pulsatile tinnitus in left ear only; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 13Apr2021 at 11:15 (at the age of 47-year-old) as a single dose for COVID-19 immunisation. Medical history included adenoidectomy (adenoid removal), scoliosis surgery and myringotomy (tubes in ears as child) and sulfonamide allergy. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 13Apr2021 at 15:00, the patient experienced loud non-pulsatile tinnitus in left ear only. The patient had not had this before. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the event loud non-pulsatile tinnitus in left ear only was not resolved at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained

Other Meds:

Current Illness:

ID: 1650330
Sex: F
Age:
State: SC

Vax Date: 04/09/2021
Onset Date: 04/05/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Lymph Node Swelling under the same arm that vaccine was given.; This is a spontaneous report from a non-contactable consumer, the patient. A 55-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: ER8733) via an unspecified route of administration in the left arm on 09Apr2021 at 13:00 as a single dose for COVID-19 immunisation. Medical history included high blood pressure. The patient did not receive any medication within two weeks of vaccination. The patient previously took non steroidal anti inflammatory drugs (MANUFACTURER UNKNOWN) for unknown indication on unknown date and experienced allergy. The patient previously received first dose of BNT162B2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, lot number: EN6207) in the left arm on 19Mar2021 at 11:00 as a single dose for Covid-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 23:00, the patient experienced lymph node swelling under the same arm that vaccine was given. No therapeutic measures were taken as a result of reported event. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event lymph node swelling under the same arm that vaccine was given was recovering at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1650331
Sex: F
Age:
State: IL

Vax Date: 04/15/2021
Onset Date: 04/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Raised rash on torso, groin, legs, chest, neck and back.; Burning & itching on skin but not at injection site; This is a spontaneous report from a contactable consumer. A 51-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 15Apr2021 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, hereditary high blood pressure and COVID-19. The patient had unspecified allergies. Concomitant medications included salbutamol (ALBUTEROL) inhaler and losartan (MANUFACTURER UNKNOWN), both taken for asthma and high blood pressure respectively from unknown dates. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 25Mar2021 at 14:00 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Apr2021 at 18:00, the patient experienced raised rash on torso, groin, legs, chest, neck and back and burning and itching on the skin but not at injection site. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events and included treatment with Benadryl and if not improved the patient planned to see the doctor. The clinical outcome of the events raised rash on torso, groin, legs, chest, neck and back and burning and itching on skin were resolving at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: ALBUTEROL [SALBUTAMOL]; LOSARTAN

Current Illness:

ID: 1650332
Sex: F
Age:
State: CT

Vax Date: 04/10/2021
Onset Date: 04/10/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Fatigue; Leg pain mostly right leg, upper thigh area; Lower back pain; Calf pain; First night after vaccine sharp abdominal pain. Didn't last long.; This is a spontaneous report from a contactable healthcare professional, the patient. A 66-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 10Apr2021 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Medical history included insomnia. Concomitant medications were not reported. The patient previously took morphine (MANAFACTURER UNKNOWN) from an unknown date for an unspecified indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021, the patient experienced sharp abdominal pain, didn't last long. On 11Apr2021, the patient experienced fatigue, then leg and lower back pain which was persistent, leg pain mostly right leg, upper thigh area at times, calf pain. The patient reported that it was really hard to say when it actually started but it appeared to have started after having vaccine. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the event sharp abdominal pain recovered on an unspecified date in Apr2021. While that of leg and lower back pain, leg pain mostly right leg, upper thigh area at times, calf pain was not recovered. No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1650333
Sex: F
Age:
State: VA

Vax Date: 04/10/2021
Onset Date: 04/11/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Swelling around the point of injection; Redness around the point of injection; itching; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: ER8731) via an unspecified route of administration in the left arm on 10Apr2021 at 11:00(at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism and insulin resistance. Concomitant medications included liothyronine (MANUFACTURER UNKNOWN), levothyroxine (MANUFACTURER UNKNOWN), metformin (MANUFACTURER UNKNOWN) and oneadayvitamin. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER7534) via an unspecified route of administration in the left arm on 20Mar2021 at 16:15 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 11Apr2021 at 12:00, the patient experienced swelling and redness around the point of injection in a circle about 1inch diameter associated with itching started 24 hours post vaccination of 2nd dose, persisted after 72hour at the time of reporting. Therapeutic measures were taken as a result of event and included treatment with anti-histamine(unspecified) from unspecified start date to unspecified stop date. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event swelling around the point of injection, redness around the point of injection and itching were recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LIOTHYRONINE; LEVOTHYROXINE; METFORMIN

Current Illness:

ID: 1650334
Sex: F
Age:
State: MI

Vax Date: 04/09/2021
Onset Date: 04/07/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Nosebleeds; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the right arm on 09Apr2021 at 14:30 hours (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history included food allergy (food sensitivities) and allergy to grass. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the right arm on 19Mar2021 at 14:30 hours (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Concomitant medications included escitalopram oxalate (LEXAPRO), lisdexamfetamine mesilate (VYVANSE), ascorbic acid (VITAMIN C), retinol (VITAMIN A), thiamine (VITAMIN B1) and cyanocobalamin (VITAMIN B12); all since an unknown date, for unknown indication and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 07Apr2021 at 23:00, the patient experienced nosebleeds. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken for the reported events. The clinical outcome of the event nosebleeds was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LEXAPRO; VYVANSE; VITAMIN C [ASCORBIC ACID]; VITAMIN A [RETINOL]; VITAMIN B1 [THIAMINE]; VITAMIN B-12

Current Illness:

ID: 1650335
Sex: F
Age:
State: NC

Vax Date: 04/14/2021
Onset Date: 04/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210313; Test Name: Antibodies; Test Result: Negative ; Test Date: 20210403; Test Name: Covid test; Test Result: Negative ; Comments: Covid test type post vaccination: Other

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Feels like I've had a stroke on right side of face; Half of face feels numb and the right side of face higher than left side of face/My cheekbone is totally numb; All bones in my face hurt very badly; Headache won't go away even with two maxalt migraine meds.; my right eye won't stop squinting; my skin my bones in my face and brain really hurt.; This is a spontaneous report from a contactable consumer (patient). This is a spontaneous report from a contactable consumer (patient). A 47-years-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Left on 14Apr2021 11:15 (Batch/Lot number was not reported) as single dose (at the age of 47) for covid-19 immunisation. Medical history included attention deficit hyperactivity disorder, anxiety, depression, insomnia, migraines, arthritis, allergy to sulfa, allergy to clarithromycin (MACROBID), allergy to amitriptyline, allergy to trazodone, allergy to tamiflu. First dose was received on 17Mar2021 12:45PM (at the age of 47) arm left. No covid prior vaccination. Covid test on 03Apr2021 was Negative. Antibodies test negative on 13Mar2021. Concomitant medications included lisdexamfetamine mesilate (VYVANSE), duloxetine, rizatriptan benzoate (MAXALT), finasteride, bupropion hydrochloride (WELLBUTRIN). The patient experienced feels like I've had a stroke on right side of face on 14Apr2021 12:00, half of face feels numb and the right side of face higher than left side of face/my cheekbone is totally numb on 14Apr2021 12:00, all bones in my face hurt very badly on 14Apr2021 12:00, headache won't go away even with two maxalt migraine meds on 14Apr2021 12:00, my right eye won't stop squinting on 14Apr2021 12:00, my skin my bones in my face and brain really hurt on 14Apr2021 12:00. Patient tried a muscle relaxer for headache and didn't help. No treatment for the other events. The events outcome was not recovered. The lot number for BNT162b2 was not provided and will be requested during follow up.

Other Meds: VYVANSE; DULOXETINE; MAXALT; FINASTERIDE; WELLBUTRIN

Current Illness:

ID: 1650336
Sex: F
Age:
State: PA

Vax Date: 04/06/2021
Onset Date: 04/09/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: The muscle where the vaccine was injected swelled quite a bit and is still swollen.; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8734) via an unspecified route of administration in the arm right on 06Apr2021 at 15:30(at the age of 58-year-old) as a single dose for COVID-19 immunisation. Medical history included sulfonamide allergy. Concomitant medications included ibuprofen (MOTRIN) from unknown for an unspecified indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6205), via an unspecified route of administration on 07Mar2021 at 15:45 as single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 the patient experienced muscle where the vaccine was injected swelled quite a bit and is still swollen. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the event muscle where the vaccine was injected swelled quite a bit and is still swollen. was recovering. No follow-up attempts are needed. No further information is expected.

Other Meds: MOTRIN [IBUPROFEN]

Current Illness:

ID: 1650337
Sex: M
Age:
State:

Vax Date: 03/01/2021
Onset Date: 03/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 202103; Test Name: Body temperature; Result Unstructured Data: Test Result:102 Units:{DF}; Comments: Fever of 102

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: Extreme muscular soreness; Fever of 102; Nausea; Headache; Fatigue; This is a spontaneous report from a non-contactable other healthcare professional. A 26-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on an unknown date in Mar2021 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. The patients' medical history was reported as none. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within two weeks of the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an intramuscular route of administration in the right arm on an unknown date in Feb2021 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On an unknown date in Mar2021, the day after the second dose only, the patient experienced extreme muscular soreness, fever of 102 (unspecified units), nausea, headache and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event's extreme muscular soreness, fever of 102 (unspecified units), nausea, headache and fatigue were resolved on an unknown date in 2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1650338
Sex: M
Age:
State: MA

Vax Date: 04/13/2021
Onset Date: 04/13/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Mild Headache; This is a spontaneous report from a contactable consumer. A 21-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration on 13Apr2021 at 12:30 (at the age of 21-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had known allergies to tree nuts. The patient did not receive any concomitant medications. The patient previously received the dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3274) via an unspecified route of administration on 22Mar2021 at 12:30 (at the age of 21-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID Vaccine. On 13Apr2021 at 20:00, the patient experienced mild headache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. It was unknown whether any therapeutic measures were taken as a result of the event. The clinical outcome of the event mild headache was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650339
Sex: F
Age:
State: CT

Vax Date: 03/31/2021
Onset Date: 04/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: FACIAL FLUSHING WITH HOT FACE; BODY ACHES; hOT AND COLD FEELING OVERALL; This is a spontaneous report from a contactable nurse, the patient. A 71-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 31Mar2021 at 15:45 (at the age of 71-year-old) as a single dose for COVID-19 immunisation. Medical history included hypertension and allergic to tetanus. Concomitant medications included olmesartan (MANUFACTURER UNKNOWN) started on an unknown date for unknown indication and hydrochlorothiazide (MANUFACTURER UNKNOWN) started on an unknown date for unknown indication. The patient did not receive any other medications or vaccines within 4 weeks prior to the vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201) via an unspecified route of administration in the left arm on 26Feb2021 at 14:30(at the age of 71-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 01Apr2021 at 09:30, the patient experienced facial flushing with hot face, body aches, hot and cold feeling overall with no fever. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events facial flushing with hot face, body aches, cold and hot feeling were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: OLMESARTAN; HYDROCHLOROTHIAZIDE

Current Illness:

ID: 1650340
Sex: F
Age:
State: WI

Vax Date: 04/12/2021
Onset Date: 04/12/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies: Lamotrigine

Symptom List: Ear pain, Hypoaesthesia

Symptoms: This is a spontaneous report from a contactable consumer (patient). A 39-year-old (non-pregnant) female patient received the second dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# ER2613), at the age of 39, via an unspecified route of administration, left arm, on Apr 12, 2021, at 10:30, single dose, for COVID-19 immunisation. Medical history included long QT syndrome and major depression. Prior to the vaccination, patient was not diagnosed with COVID-19. The patient previously took lamotrigine on an unknown date for an unknown indication and experienced allergy. The patient previously received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# EW0158), at the age of 39, via an unspecified route of administration, on Mar 22, 2021, at 10:30, single dose, for COVID-19 immunisation. Concomitant medications included potassium, nadolol and desvenlafaxine; all for unknown indication from unknown dates and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On Apr 12, 2021, patient experienced nausea, brain fog, dizziness, some cotton mouth, malaise, fatigue and pain in injection site. No therapeutic measures taken as a result of the events. The events did not result in doctor/other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, patient has not been tested for COVID-19. The outcome of nausea, brain fog, dizziness, some cotton mouth, malaise, fatigue and pain in injection site: not recovered (at the time of this report). No follow-up attempts possible. No further information expected.

Other Meds: Potassium; Nadolol; Desvenlafaxine

Current Illness:

ID: 1650341
Sex: F
Age:
State:

Vax Date: 04/12/2021
Onset Date: 04/12/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Chills; Fever; Headache; This is a spontaneous report from a non-contactable healthcare professional, the patient. A 30-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 12Apr2021 at 09:45 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Other medical history not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 19Mar2021 at 10:00 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Apr2021 at 23:00, the patient experienced chills, fever and headache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills, fever and headache was not resolved at the time of this report. No follow-up attempts are possible. No further information is expected

Other Meds:

Current Illness:

ID: 1650342
Sex: F
Age:
State: NC

Vax Date: 04/09/2021
Onset Date: 04/09/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Swollen uvula; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration in the left arm on 09Apr2021 at 11:30 (at the age of 45-year-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high (HBP) and penicillin allergy. Concomitant medications included metoprolol (MANUFACTURER UNKNOWN), duloxetine hydrochloride (CYMBALTA) and lisinopril (MANUFACTURER UNKNOWN) for unknown indication from unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 16:00, the patient experienced swollen uvula. No therapeutic measures were taken as a result of the reported event. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event swollen uvula was resolved on an unknown date in Apr2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: METOPROLOL; CYMBALTA; LISINOPRIL

Current Illness:

ID: 1650343
Sex: F
Age:
State: NY

Vax Date: 04/04/2021
Onset Date: 04/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Rash started right side of neck (15Apr)midday, clear up and rash appear left top side on back and lightly in vaccine arm area; Rash start right side of neck (15Apr)midday, clear up and rash appear left top side on my back andlightly in vaccine arm area.; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the right arm on 04Apr2021 at 08:30 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history included anemia and periodontal disease. Concomitant medications included iron (MANUFACTURER UNKNOWN) and probiotic (MANUFACTURER UNKNOWN) for an unknown indication from an unspecified date and unknown if ongoing. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 15Apr2021 at 12:00, the patient experienced rash started right side of neck, clear up and rash appear left top side on back and lightly in vaccine arm area. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event rash started right side of neck, clear up and rash appear left top side on back and lightly in vaccine arm area was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: IRON; PROBIOTICS NOS

Current Illness:

ID: 1650344
Sex: M
Age:
State: ID

Vax Date: 04/15/2021
Onset Date: 04/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: A little while after the shot started getting a sharp pain in right foot, it is very sudden.; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 15Apr2021 at 14:45 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. The patient did not receive any other medications within two weeks of vaccination. On 15Apr2021 at 15:45, a little while after the shot, the patient started getting a sharp pain in the right foot, it was very sudden and lasted for a few seconds then gone away for a while. It had occurred every 30 minutes or so since about 2 hours after the shot. The patient did not receive any treatment for the events. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event sharp pain in right foot was not recovered at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1650345
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Fever within 24 hours after 2nd dose of vaccine; Chills within 24 hours after 2nd dose of vaccine; This is a spontaneous report from a non-contactable consumer. A female patient of an unspecified age received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. The patients' medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On an unknown date, within 24 hours after the second dose, the patient experienced fever and chills. Therapeutic measures were not taken as a result of the events. Since the vaccination, it was unknown if the patient had been tested for COVID-19. The clinical outcome of the events fever and chills were resolved on an unknown date. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1650346
Sex: F
Age:
State:

Vax Date: 04/11/2021
Onset Date: 04/12/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: All joints stiff; Hands feel as though they are swollen; Headache; Body ache; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration on 11Apr2021 at 19:30 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included sulfonamide allergy (sulfas allergy) and protein allergy (whey Proteins). Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other medications or vaccines within 4 weeks prior to the COVID vaccine. On 12Apr2021 at 00:00, the patient experienced all joints stiff, hands felt as though they were swollen, head and body ache x2days. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events headache and body ache were recovered on 14Apr2021. The clinical outcome of the events all joints stiff, hand felt swollen were recovering at the time of this report. No follow up attempts needed; information about lot number cannot be obtained.

Other Meds:

Current Illness:

ID: 1650347
Sex: M
Age:
State: OH

Vax Date: 04/05/2021
Onset Date: 04/09/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Nodules in arm pit of left arm; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 05Apr2021 at 15:00 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. The patient medical history was reported as none. The patient allergies to medications, food, or other products were reported as none known. The patient did not receive any other medications within 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 09Apr2021, the patient experienced nodules in arm pit of left arm. Therapeutic measures were not taken as a result of the event. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event nodules in arm pit of left arm was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650348
Sex: F
Age:
State: CA

Vax Date: 03/26/2021
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Name: Pregnancy test; Test Result: Negative

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Missed period; abnormally high amounts of clear, non-stretchydischarge; This is a spontaneous report from a non-contactable consumer, the patient. A 39-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ZR8730) via an unspecified route of administration on 26Mar2021 at 18:00 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in 2021, the patient had missed period with abnormally high amounts of clear, non-stretchy discharge. The events did not result in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as the result of adverse events. Since the vaccination, the patient had not been tested for COVID-19. The patient underwent for pregnancy test on an unknown date and the results were found to be negative. The clinical outcome of the events missed period with abnormally high amounts of clear, non-stretchy discharge were unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650349
Sex: M
Age:
State: VA

Vax Date: 03/23/2021
Onset Date: 03/24/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Migraine; Anxiety; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 23Mar2021 at 10:00 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Concomitant medications were not reported. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Mar2021 at 15:00, the patient experienced migraine and anxiety. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events migraine and anxiety was unknown at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1650350
Sex: F
Age:
State: CA

Vax Date: 04/09/2021
Onset Date: 04/09/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Numbness of right arm down to the fingers; Slight swelling of the right arm down to the fingers; Facial swelling around the mouth and cheeks; Accelerated heart rate; This is a spontaneous report from a contactable consumer. A 57-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 09Apr2021 at 14:30 (at the age of 57-year-old) as a single dose for COVID-19 immunisation. Medical history included sulfonamide allergy. The patient previously took ciprofloxacin and experienced drug allergy. The patient was allergic to sulfa drugs and ciprofloxacin. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within two weeks of vaccination. On 09Apr2021 at 15:00, the patient experienced numbness and slight swelling of the right arm down to the fingers within first 30 minutes and continued for several hours then reduced to light swelling without numbness into the next day and then "tapered off". On 09Apr2021 first night of vaccine, patient noticed that facial swelling around the mouth and cheeks with slight numbness which disappeared during the day then returned again next night with less noticeable swelling around the mouth. On 09Apr2021 and 10Apr2021, during the first and second night of vaccine patient noticed an accelerated heart rate which kept patient up for a few hours but patient felt asleep and awoke fine. Patient was told that she was breathing "funny" like a dog on the first night of vaccine which prompted her fiance to woke up and make sure she was fine. Patient felt fine when she was awakened. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the events numbness and slight swelling of the right arm down to the fingers was recovered on 10Apr2021 after the duration of 1 day. The outcome of the event accelerated heart rate was recovered on 11Apr2021 after the duration of 2 days. while the event of facial swelling around the mouth and cheeks was recovered on unspecified date Apr2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1650351
Sex: F
Age:
State: NE

Vax Date: 04/01/2021
Onset Date: 04/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Nerve pain; internal tremors; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: EL9264) via an unspecified route of administration in the left arm on 01Apr2021 at 15:45 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history of the patient was not reported. The patient had known allergies to gluten, dairy and shellfish. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the left arm on 12Mar2021 at 11:30 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 02Apr2021, at 12:00 hours, the patient experienced nerve pain. On an unknown date in Apr2021, the patient experienced internal tremors. Therapeutic measures were not taken as a result of the reported adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event internal tremors was unknown at the time of report. The clinical outcome of the event nerve pain was recovered on 03Apr2021, after the duration of 12 hours. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1650352
Sex: M
Age:
State:

Vax Date: 03/01/2021
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: Intense chills; aches; headache; general fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 22-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in Mar2021 (at the age of 22-year-old) and received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration on 12Apr2021 (at the age of 22-year-old)as a single dose for COVID-19 immunisation. Medical history were reported as none. The patient did not receive any other medications within two weeks of vaccination. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in 2021, the patient experienced intense chills, aches, headache and general fatigue. Therapeutic measures were not taken as a result of the reported events. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the events intense chills, aches, headache and general fatigue was resolving at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1650353
Sex: M
Age:
State: FL

Vax Date: 04/15/2021
Onset Date: 04/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Injection site soreness and tense area; Injection site soreness and tense area; Cannot lift the arm up from tightness and slight pain; Pain only when attempting to lift arm; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 15Apr2021 at 13:30 (at the age of 36-years-old), as a single dose for COVID-19 immunisation. Medical history included high blood pressure. Concomitant medications included hydrochlorothiazide, losartan (HYDROCHLOROTHIAZIDE; LOSARTAN) for unspecified indication from unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 15Apr2021 at 21:00, the patient experienced injection site soreness and tense area, could not lift the arm up from tightness and slight pain and experienced pain only when attempting to lift arm. The patient felt as if got hit in the area and had resulted in soreness. The patient was keeping arm down, but rotating hand rotor cuff resulted in muscle movement at the injection site (upper arm) and caused slight pain at site. Thus, patient needed to keep arm down and tucked to body. The patient had no other effects at the time of reporting. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event injection site soreness and tense area, cannot lift the arm up from tightness and slight pain and pain only when attempting to lift arm was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: HYDROCHLOROTHIAZIDE;LOSARTAN

Current Illness:

ID: 1650354
Sex: F
Age:
State: FL

Vax Date: 04/09/2021
Onset Date: 04/09/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Chills; Fever; Muscle aches; This is a spontaneous report from a non-contactable nurse, the patient. A 61-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8737) via an unspecified route of administration in the left arm on 09Apr2021 at 14:00 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history included history of cancer, no chronic conditions and COVID-19. The patient did not have any allergies to medication, food or other products. Concomitant medications included curcuma longa rhizome (TURMERIC) and multivitamin (Unspecified); from an unknown date for unknown indication and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on 19Mar2021 at 14:00 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 (also reported start time as 23:30), 10 hours after vaccine, the patient experienced chills, fever and muscle aches. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events chills, fever and muscle aches were resolved on 11Apr2021 (lasting 2 days). No follow-up attempts are possible. No further information is expected.

Other Meds: TURMERIC [CURCUMA LONGA RHIZOME]

Current Illness:

ID: 1650355
Sex: M
Age:
State:

Vax Date: 04/09/2021
Onset Date: 04/10/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: feeling dizzy; Nauseous; Vomiting; This is a spontaneous report from a non-contactable consumer, the patient. A 16-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: EN6198) via an unspecified route of administration in the left arm on 09Apr2021 (at the age of 16-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Since the vaccination, the patient had not been tested for COVID-19. On 10Apr2021 at 10:00 the patient experienced feeling dizzy, nauseous and vomiting. The patient had reported of feeling dizzy and nauseous before vomiting. The patient appeared to feel recovered approximately 12 hours later. No therapeutic measures were taken as a result of the reported adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events of feeling dizzy, nauseous and vomiting was recovered on 10Apr2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1650356
Sex: M
Age:
State:

Vax Date: 04/11/2021
Onset Date: 04/11/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: Slight fever; Chills; Headache; Fatigue; Pain in left arm; This is a spontaneous report from a non-contactable consumer, the patient. A 47-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 11Apr2021 at 10:45(at the age of 47-year-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient had no known allergies to food, medications or other products. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration on 22Mar2021 (at the age of 47-year-old) as a single dose for COVID-19 immunisation. On 11Apr2021 at 15:30 the patient experienced slight fever, chills, headache, fatigue and pain in left arm. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events, slight fever, chills, headache, fatigue and pain in left arm was recovered on unknown date on Apr2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1650357
Sex: M
Age:
State:

Vax Date: 04/13/2021
Onset Date: 04/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Burning sensation covering entire body; Sudden flashes of intense cold; Dizziness; Dull ache in the balls; This is a spontaneous report from a non-contactable consumer, the patient. A 19-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the right arm on 13Apr2021 (at the age of 19-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 14Apr2021 at 03:00, the patient experienced a burning sensation covering the entire body with sudden flashes of intense cold alongside dizziness that persisted even when lain down, topped off with a dull ache in the balls. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events burning sensation covering entire body, sudden flashes of intense cold, dizziness, and dull ache in the balls were recovering at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1650358
Sex: F
Age:
State: UT

Vax Date: 04/14/2021
Onset Date: 04/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Chills; Fatigue; Full body ache; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 14Apr2021 at 17:30 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. It was unknown whether the patient was pregnant at the time of vaccination. The patient did not have any allergies to medications, food, or other products. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 24Mar2021 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 15Apr2021 at 09:00 the patient experienced chills, fatigue and full body ache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcomes of the events chills, fatigue and full body ache were not recovered. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1650359
Sex: F
Age:
State: WI

Vax Date: 04/14/2021
Onset Date: 04/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210416; Test Name: Body temperature; Result Unstructured Data: Test Result:99 Units: Comments: 99 Now fever has been at 99 for another 12 hours; Test Date: 20210415; Test Name: Body temperature; Result Unstructured Data: Test Result:100.6 Units: Comments: 100.6 Fever of 100.6 for 12 hours

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Fever of 100.6 for 12 hours. Now fever has been at 99 for another 12 hours; Arm was immovable; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the right arm on 14Apr2021 at 10:00 (at the age of 37-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not have any allergies to medications, food or other products. The patient did not receive any other medications in two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration on an unknown date in 2021 (at the age of 37-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Apr2021 at 18:00, the patient experienced fever of 100.6 for 12 hours, now fever has been at 99 for another 12 hours and arm was immovable until 11:00 this morning since yesterday the day of vaccine at 6. The patient had no reaction to the first dose. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. On 15Apr2021 at 18:00, the patient underwent lab test and procedure which included body temperature and result was shown as 100.6 (units unspecified). On 16Apr2021, the patient underwent lab test and procedure which included body temperature and result was shown as 99 (units unspecified). The clinical outcome of the events fever of 100.6 for 12 hours, now fever has been at 99 for another 12 hours was resolving and the clinical outcome of arm was immovable was resolved on 16Apr2021 at 11:00. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1650360
Sex: F
Age:
State: WA

Vax Date: 04/13/2021
Onset Date: 04/13/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Rash at the injection site; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the arm left on 13Apr2021 at 11:00 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Medical history included mild TBI (traumatic brain injury), aneurysm, craniotomy (for aneurysm) and brain swelling in 2014. Concomitant medications included levetiracetam (KEPPRA), cetirizine hydrochloride (ZYRTEC), montelukast sodium (SINGULAIR), norethisterone (NORETHINDRONE) and hydrochlorothiazide (HYDROCHLOROTH), all started from an unspecified date and for an unknown indication, and taken within two weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunisation. The patient previously received doxycycline (MANUFACTURER UNKNOWN) and sulfamethoxazole; trimethoprim(BACTRIM) on unknown dates and for unknown indications which caused drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 13Apr2021 at 12:00, the patient developed a rash at the injection site. The rash had progressively gotten larger over the past few days since receiving the shot. No therapeutic measures were taken as a result of the event. The event did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. The clinical outcome of the event rash at the injection site was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: KEPPRA [LEVETIRACETAM]; ZYRTEC [CETIRIZINE HYDROCHLORIDE]; SINGULAIR; NORETHINDRONE [NORETHISTERONE]; HYDROCHLOROTH

Current Illness:

ID: 1650361
Sex: M
Age:
State: OR

Vax Date: 03/23/2021
Onset Date: 03/31/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Presumably viral, pharyngitis; Oral mucosal cold sores; This is a spontaneous report from a contactable pharmacist. A 45-year-old male patient received the unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via intramuscular route of administration in the right arm on 23Mar2021 at 17:30(at the age of 45-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. The patient had no known allergies to medications, food or other products. Patient did not receive any other medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 31Mar2021, the patient experienced presumably viral pharyngitis and oral mucosal cold sores. The patient did not receive any treatment for the event. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event presumably viral pharyngitis and oral mucosal cold sores was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650362
Sex: M
Age:
State: NJ

Vax Date: 04/12/2021
Onset Date: 04/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: Blood test; Result Unstructured Data: Test Result:No anomalies were found; Test Name: electrocardiogram; Result Unstructured Data: Test Result:No anomalies were found; Test Name: chest x-ray; Result Unstructured Data: Test Result:No anomalies were found; Test Name: Body temperature; Result Unstructured Data: Test Result:100 Units:[degF]; Comments: elevated temp not rising above 100 degF.

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: chills; nausea; an elevated temp not rising above 100degF; sharp pain in chest/abdomen on the left side; sharp pain in chest/abdomen on the left side; It was made much worse when taking a deep breath or a deep exhalation/ The next day the pain had worsened and lying down in any position was debilitatingly painful with any breathing.; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 12Apr2021 at 15:15 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. Medical history included fatty liver (Recent diagnosis of slight Fatty Liver in the past 6 weeks). Patient had no known allergies. Concomitant medications included bupropion (MANUFACTURER UNKNOWN) 200 mg one daily, and fluoxetine (MANUFACTURER UNKNOWN) 20 mg one daily, both from an unknown date for an unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 08:00, the patient experienced awoke to a sharp pain in chest/abdomen on the left side. The pain was such that he could not lay on that side. It was made much worse when taking a deep breath or a deep exhalation. On 15Apr2021, the patient experienced the pain had worsened and lying down in any position was debilitatingly painful with any breathing. Concurrently he experienced chills, nausea, and an elevated temp not rising above 100 degF. Patient reported that his GP and GI doctor referred him to the ER where a chest x-ray, EKG, and bloodwork was taken. No anomalies were found; spleen was not enlarged. Both the GI doctor prior and separately the ER doctor speculated it may be related to the vaccine (potentially causing inflammation) given the timeframe of onset. The events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events awoke to a sharp pain in chest/abdomen on the left side, the pain was such that he could not lay on that side. It was made much worse when taking a deep breath or a deep exhalation, pain had worsened and lying down in any position was debilitatingly painful with any breathing, experienced chills, nausea, and an elevated temp not rising above 100 degF was recovering. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: BUPROPION; FLUOXETINE

Current Illness:

ID: 1650363
Sex: F
Age:
State: CO

Vax Date: 04/03/2021
Onset Date: 04/04/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: The tinnitus on my right ear is louder than usual, and the noise type now has frequent variations--noticed this change after the other symptoms went away; Had arm pain, low grade fever, tiredness, and a headache on April 4th and 5th.; Had arm pain, low grade fever, tiredness, and a headache on April 4th and 5th.; Had arm pain, low grade fever, tiredness, and a headache on April 4th and 5th.; Had arm pain, low grade fever, tiredness, and a headache on April 4th and 5th.; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 03Apr2021 at 16:45 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history included rosacea, tinnitus, acne cystic, marginal eye ulcers. The patient previously had peanut and experienced mild peanut allergy. Concomitant medications taken within two weeks of vaccination included tretinoin (MANUFACTURER UNKNOWN), metronidazole (MANUFACTURER UNKNOWN), simeticone (GAS-X) and cetirizine hydrochloride (ZYRTEC), antiacids; all from unknown date for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had arm pain, low grade fever, tiredness, and a headache on 04Apr2021 and 05Apr2021. On 06Apr2021 the patients tinnitus on her right ear was louder than usual, and the noise type had frequent variations-- she noticed this change after the other symptoms went away. No therapeutic measures were taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events arm pain, low grade fever, tiredness, and a headache on 04Apr2021 and 05Apr2021 was resolved on 05Apr2021. The clinical outcome of the event tinnitus on right ear was louder than usual, and the noise type had frequent variations-- noticed this change after the other symptoms went away was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: TRETINOIN; METRONIDAZOLE; GAS-X; ZYRTEC [CETIRIZINE HYDROCHLORIDE]

Current Illness:

ID: 1650364
Sex: F
Age:
State: MD

Vax Date: 03/30/2021
Onset Date: 03/30/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Lower half of face swelled; Lips swollen; Tongue swollen; Face and lips flushed bright red; Voice became hoarse; Hot flashes through chest and arms; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the left arm on 30Mar2021 at 18:45 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included autoimmune allergic condition (autoimmune disorder), allergy to sulfa drugs and allergy to shellfish since unknown dates. Concomitant medications included fluoxetine (MANUFACTURER UNKNOWN), vitamin d nos (VITAMIN D) and lovastatin (MANUFACTURER UNKNOWN); all for an unknown indications and from unknown dates. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 30Mar2021 at 18:45, the patient experienced lower half of face swelled, lips and tongue swollen, face and lips flushed bright red, voice became hoarse, hot flashes through chest and arms. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events lower half of face swelled, lips swollen, tongue swollen, face and lips flushed bright red, voice became hoarse and hot flashes through chest and arms were resolved on an unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds: FLUOXETINE; VITAMIN D NOS; LOVASTATIN

Current Illness:

ID: 1650365
Sex: F
Age:
State: FL

Vax Date: 04/08/2021
Onset Date: 04/09/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Headache; Nausea; Fatigue; Vomiting; Stomach Pains; Chills; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 08Apr2021 at 10:45 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient was allergic to ampicillin (MANUFACTURER UNKNOWN) and Augmentin antibiotics. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on 18Mar2021 at 10:45 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 09Apr2021 at 04:00 the patient experienced headache, nausea, fatigue, vomiting, stomach pains and chills. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcomes of the events headache, nausea, fatigue, vomiting, stomach pains and chills were recovered on unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650366
Sex: M
Age:
State: OH

Vax Date: 04/01/2021
Onset Date: 04/05/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Left arm pain/extending to left hand; Neck pain; Swollen lymph node in left neck area; Tingling in hand; Tired; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP7533) via an unspecified route of administration in the left arm on 01Apr2021 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included allergies to contrast dye, latex and neoprene. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6199) via an unspecified route of administration in the left arm on 06Mar2021 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 the patient experienced left arm pain, neck pain within 1 week of 2nd dose, swollen lymph node in left neck area, continuing pain in left arm, extending to left hand, tingling in hand, tired. The events resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of the events. The clinical outcome of the events left arm pain/extending to left hand, neck pain, swollen lymph node in left neck area, tingling in hand and tired were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650367
Sex: M
Age:
State: OH

Vax Date: 04/12/2021
Onset Date: 04/12/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: Tiredness; Nausea; Light cold; This is a spontaneous report from a non-contactable consumer, the patient. A 28-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the left arm on 12Apr2021 at 12:00 (at the age of 28-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 12Apr2021 at 14:00, the patient experienced tiredness, nausea and light cold for 3 hours. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome for the events tiredness, nausea and cold were recovered on 12May2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1650368
Sex: M
Age:
State: CA

Vax Date: 03/12/2021
Onset Date: 03/16/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Severe pain; Soreness of both hands. It was difficult to hold onto a full coffee mug with both hands. My right hand still hurts if fingers are squished together, 4 weeks after 2nd dose of vaccine.; Aching of lower back; Aching of lower back, sacroiliac joints; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on 12Mar2021 at 10:30 (at the age of 65-year-old) as a single dose for COVID-19 immunisation. Medical history included reitners syndrome, reactive arthritis, kidney disease and shellfish allergy. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 16Mar2021, the patient experienced severe pain, aching, soreness of both hands. It was difficult to hold onto a full coffee mug with both hands, aching of lower back and sacroiliac joints. These symptoms lasted 2 to 3 weeks. His right hand still hurts if fingers were squished together, 4 weeks after second dose of vaccine. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of these events and included treatment with acetaminophen (MANUFACTURER UNKNOWN) at bed time to afford sleeping. The clinical outcome of the events severe pain, aching, soreness of both hands, difficult to hold onto a full coffee mug with both hands, aching of lower back, sacroiliac joints and his right hand still hurts if fingers were squished together was recovered with lasting effects. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650369
Sex: F
Age:
State:

Vax Date: 04/10/2021
Onset Date: 04/11/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Headache; Overall soreness; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the right arm on 10Apr2021 at 12:00 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Other medical history not reported. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the right arm on 20Mar2021 at 12:00 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Apr2021, the patient experienced headache and overall soreness. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache and overall soreness was recovered on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650370
Sex: M
Age:
State: MI

Vax Date: 04/12/2021
Onset Date: 04/13/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Woke up with bloody nose morning after vaccine; sore arm; This is a spontaneous report from a contactable consumer, the patient. An 18-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 12Apr2021 at 16:00 as a single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient did not have any known allergies. The patient did not take any other vaccines in four weeks. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not tested positive for COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 13Apr2021 at 09:30, the patient woke up with bloody nose, the morning after the vaccine and other symptom was sore arm. Therapeutic measures were not taken as a result of the adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events- bloody nose and sore arm was recovered on 13Apr2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1650371
Sex: M
Age:
State: OH

Vax Date: 04/11/2021
Onset Date: 04/12/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210412; Test Name: Body temperature; Result Unstructured Data: Test Result:Over 101; Comments: At 02:00

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Strong body aches; Weakness; Chills; Fever over 101; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 11Apr2021 at 13:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. The patients' medical history was reported as none. The patient had no known allergies to any medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 21Mar2021 at 13:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 12Apr2021 at 02:00, the patient experienced strong body aches, weakness, chills and a fever over 101 (unspecified units). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events strong body aches, weakness, chills, fever over 101 was resolved on an unspecified date in Apr2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1650372
Sex: M
Age:
State: CT

Vax Date: 04/12/2021
Onset Date: 04/13/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Fatigued; Lightheadedness; Sweating; Mild fever-like symptoms; This is a spontaneous report from a non-contactable consumer, the patient. A 26-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the arm left on 12Apr2021 at 09:45 (at the age of 26-year-old) as a single dose for COVID-19 immunisation. Medical history included constipation predominant irritable bowel syndrome (IBS-C). Concomitant medication included PSYLLIUM fiber capsules started on an unknown date for unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the arm left on 22Mar2021 at 11:00 (at the age of 26-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 at 04:00, the patient woke up with mild fever-like symptoms, sweating and lightheadedness. The patient fell back asleep at 05:00 and woke up at 07:30 without symptoms, just fatigued. Therapeutic measures were not taken as a result of these events. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events lightheadedness, sweating, mild fever-like symptoms and fatigued was recovered on 13Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: PLANTAGO AFRA

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am